Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
نویسندگان
چکیده
منابع مشابه
Taking Renin-Angiotensin Drugs in Patients with COVID-19: Start, Continue, or Stop; a Literature Review
Considering the pandemic of the COVID-19 disease, the use of various drugs in patients has been investigated. Recently, numerous studies have been done on the effectiveness of drugs which used to treat the underlying disease such as congestive heart failure, hypertension, as well as coronary artery disease in various countries, because the patients with underlying conditions are more likely ...
متن کاملPrevalence of Psychological Disorders in Patients with COVID-19 Syndrome
A B S T R A C T The coronavirus 2019 first broke out on December 17, 2019 in Wuhan, China, and on March 11, 2020, it was announced as a worldwide pandemic by the World Health Organization. Despite nutritious diets and promising vaccines, health tips such as wearing a mask, social distancing, home quarantine, and not traveling are still the best ways to control the spread of COVID-19.While the ...
متن کاملCT Scan Findings in Patients with COVID-19
Background and purpose: Lung involvement is highly important in patients with Coronavirus disease 2019 (COVID-19) and CT scan plays a major role in diagnosis and treatment of patients. This study investigated a large sample size of COVID-19 patients who performed CT scan. Materials and methods: This descriptive cross-sectional study was done using the CT scan findings of all suspected, probabl...
متن کاملA Narrative Review on Evaluation of Hypercoagulability State in Severe Covid-19 Patients with Background Risk Factors
Coronavirus disease (COVID-19) can induce coagulopathy at the base of sepsis-induced coagulopathy (SIC), which is an important cause of death in these patients. Cytokine storm causes imbalance in coagulation and fibrinolytic system. A combination of hypercoagulability state, decrease or inhibition of fibrinolysis and endotheliopathy causes thromboembolic events. Underlying diseases such as diab...
متن کاملHematology findings in patients with Coronavirus disease 2019 (COVID-19)
In December 2019, Wuhan, the capital of Hubei Province in China, became the center of an outbreak of pneumonia with unknown etiology. By 7 January 2020, Chinese scientists have isolated a new coronavirus from patients with viral infectious pneumonia, the Coronavirus 2 Acute Respiratory Syndrome (SARS-CoV-2), previously called 2019-nCoV. The disease was later diagnosed as coronavirus 2019 (COVID...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: New England Journal of Medicine
سال: 2020
ISSN: 0028-4793,1533-4406
DOI: 10.1056/nejmoa2015301